TECON BIOLOGYLTD Past Earnings Performance
Past criteria checks 0/6
TECON BIOLOGYLTD's earnings have been declining at an average annual rate of -47.8%, while the Food industry saw earnings growing at 3.1% annually. Revenues have been growing at an average rate of 21.4% per year.
Key information
-47.8%
Earnings growth rate
-47.2%
EPS growth rate
| Food Industry Growth | 7.2% |
| Revenue growth rate | 21.4% |
| Return on equity | -18.1% |
| Net Margin | -6.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How TECON BIOLOGYLTD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 18,912 | -1,295 | 1,084 | 279 |
| 31 Dec 23 | 19,026 | -1,363 | 1,047 | 253 |
| 30 Sep 23 | 18,810 | -482 | 995 | 232 |
| 30 Jun 23 | 17,944 | -69 | 993 | 193 |
| 31 Mar 23 | 17,488 | 336 | 961 | 178 |
| 01 Jan 23 | 16,989 | 281 | 1,022 | 176 |
| 30 Sep 22 | 16,267 | -252 | 1,190 | 187 |
| 30 Jun 22 | 15,803 | -1,042 | 1,265 | 184 |
| 31 Mar 22 | 15,764 | -1,073 | 1,350 | 180 |
| 01 Jan 22 | 15,711 | -703 | 1,364 | 168 |
| 30 Sep 21 | 15,695 | 50 | 1,365 | 102 |
| 30 Jun 21 | 15,200 | 1,128 | 1,448 | 107 |
| 31 Mar 21 | 13,343 | 1,687 | 1,408 | 106 |
| 31 Dec 20 | 11,987 | 1,720 | 1,287 | 101 |
| 30 Sep 20 | 10,917 | 1,820 | 1,278 | 124 |
| 30 Jun 20 | 9,465 | 1,398 | 1,166 | 89 |
| 31 Mar 20 | 8,255 | 950 | 1,071 | 89 |
| 31 Dec 19 | 7,476 | 644 | 1,030 | 80 |
| 30 Sep 19 | 6,742 | 356 | 883 | 82 |
| 30 Jun 19 | 5,701 | 286 | 701 | 91 |
| 31 Mar 19 | 5,481 | 287 | 666 | 74 |
| 31 Dec 18 | 5,273 | 314 | 629 | 74 |
| 30 Sep 18 | 4,875 | 346 | 551 | 105 |
| 30 Jun 18 | 4,647 | 325 | 560 | 83 |
| 31 Mar 18 | 4,587 | 355 | 567 | 66 |
| 31 Dec 17 | 4,630 | 407 | 564 | 54 |
| 30 Sep 17 | 4,654 | 394 | 650 | 0 |
| 30 Jun 17 | 4,550 | 390 | 665 | 0 |
| 31 Mar 17 | 4,521 | 403 | 659 | 0 |
| 31 Dec 16 | 4,444 | 393 | 668 | 0 |
| 30 Sep 16 | 4,268 | 353 | 666 | 0 |
| 30 Jun 16 | 4,260 | 297 | 631 | 0 |
| 31 Mar 16 | 4,105 | 293 | 636 | 0 |
| 31 Dec 15 | 4,167 | 246 | 649 | 0 |
| 30 Sep 15 | 4,394 | 302 | 627 | 0 |
| 30 Jun 15 | 4,488 | 274 | 667 | 0 |
| 31 Mar 15 | 4,492 | 236 | 647 | 0 |
| 31 Dec 14 | 4,236 | 236 | 591 | 0 |
| 30 Sep 14 | 3,978 | 197 | 527 | 0 |
| 30 Jun 14 | 3,823 | 201 | 476 | 0 |
| 31 Mar 14 | 3,638 | 167 | 430 | 0 |
| 31 Dec 13 | 3,725 | 170 | 430 | 0 |
| 30 Sep 13 | 3,470 | 134 | 409 | 0 |
| 30 Jun 13 | 3,437 | 118 | 387 | 0 |
Quality Earnings: 002100 is currently unprofitable.
Growing Profit Margin: 002100 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002100 is unprofitable, and losses have increased over the past 5 years at a rate of 47.8% per year.
Accelerating Growth: Unable to compare 002100's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002100 is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (1.2%).
Return on Equity
High ROE: 002100 has a negative Return on Equity (-18.13%), as it is currently unprofitable.